Skip to main content
Clinical Trials/NCT01521858
NCT01521858
Completed
Not Applicable

Relations Between Hematologic Variables and Postoperative Bleeding in Total Hip Replacement Arthroplasty

Seoul National University Bundang Hospital1 site in 1 country73 target enrollmentJanuary 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Avascular Necrosis of Hip
Sponsor
Seoul National University Bundang Hospital
Enrollment
73
Locations
1
Primary Endpoint
Rotational thromboelastometry
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

Total hip replacement arthroplasty is a surgery having intra- and postoperative substantial blood loss. The investigators will investigate the relationship between the various hematologic variables and postoperative bleeding volume.

Registry
clinicaltrials.gov
Start Date
January 2012
End Date
February 2013
Last Updated
12 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Hyo-Seok Na

Assistant professor

Seoul National University Bundang Hospital

Eligibility Criteria

Inclusion Criteria

  • avascular necrosis of hip
  • total hip replacement arthroplasty

Exclusion Criteria

  • revision operation
  • hematologic disease
  • anticoagulant medication
  • preoperative hemoglobin \< 10 g/dl
  • preoperative transfusion of red blood cells

Outcomes

Primary Outcomes

Rotational thromboelastometry

Time Frame: preoperative 1 day and postoperative 1 day

postoperative bleeding volume

Time Frame: at first postoperative day

Hemoglobin

Time Frame: preoperative 1 day and postoperative 1 day

hematocrit

Time Frame: preoperative 1 day and postoperative 1 day

activated partial prothrombin time

Time Frame: preoperative 1 day and postoperative 1 day

fibrinogen concentration

Time Frame: preoperative 1 day and postoperative 1 day

platelet

Time Frame: preoperative 1 day and postoperative 1 day

prothrombin time_international normalized ratio

Time Frame: preoperative 1 day and postoperative 1 day

Secondary Outcomes

  • volume of infused fluid during operation(Period from starting to finishing the operation (During operaiton, an expected average of 3 hours))
  • intraoperative urine output(Period from starting to finishing the operation (During operaiton, an expected average of 3 hours))
  • transfusion units(Period from starting to finishing the operation (During operaiton, an expected average of 3 hours) and postoperative first day)

Study Sites (1)

Loading locations...

Similar Trials